Electromed (ELMD) Stock Price, News & Analysis

Company Overview

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Key Stats

• Today's Range: $18.22 to $20.17
• 50-Day Range: $14.35 to $19.83
• 52-Week Range: $9.53 to $20.18
• Volume: 463,868 shs
• Average Volume: 33,202 shs
• Market Capitalization: $171.65 million
• P/E Ratio: 39.66
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ELMD Stock Analysis - Frequently Asked Questions

How have ELMD shares performed this year?

Electromed's stock was trading at $10.91 at the beginning of the year. Since then, ELMD stock has increased by 81.8% and is now trading at $19.83.
View the best growth stocks for 2024 here.

How were Electromed's earnings last quarter?

Electromed, Inc. (NYSE:ELMD) announced its quarterly earnings data on Tuesday, August, 27th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.14 by $0.06. The company earned $14.83 million during the quarter. Electromed had a trailing twelve-month return on equity of 12.44% and a net margin of 9.41%.

Who are Electromed's major shareholders?

Electromed's top institutional shareholders include Dimensional Fund Advisors LP (3.23%), Renaissance Technologies LLC (1.19%), Gabelli Funds LLC (0.45%) and Pekin Hardy Strauss Inc. (0.40%).
View institutional ownership trends.

How do I buy shares of Electromed?

Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 8/27/2024
• Today: 9/17/2024
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:ELMD
• CUSIP: N/A
• CIK: 1488917
• Web: smartvest.com
• Phone: (952) 758-9299
• Fax: 866-758-5077
• Employees: 160
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.50
• Trailing P/E Ratio: 39.66
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $5.15 million
• Net Margins: 9.41%
• Pretax Margin: 12.86%
• Return on Equity: 12.44%
• Return on Assets: 10.72%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.75
• Quick Ratio: 5.27

Sales & Book Value

• Annual Sales: $54.72 million
• Price / Sales: 3.14
• Cash Flow: $0.78 per share
• Price / Cash Flow: 25.49
• Book Value: $5.15 per share
• Price / Book: 3.85

Miscellaneous

• Outstanding Shares: 8,656,000
• Free Float: 7,557,000
• Market Cap: $171.65 million
• Optionable: Optionable
• Beta: 0.27